Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 83, Issue 3, 1999, Pages 376-382

  Aukrust, Pål ^a   Ueland, Thor ^b   Lien, Egil ^c   Bendtzen, Klaus ^d   Müller, Fredrik ^a   Andreassen, Arne K ^b   Nordøy, Ingvild ^a   Aass, Halfdan ^b   Espevik, Terje ^c   Simonsen, Svein ^c   Frøland, Stig S ^a   Gullestad, Lars ^b  

^a Sect Clin Immunol Infect Dis   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; MONOCYTE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CYTOKINES; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL ISCHEMIA; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR; STROKE VOLUME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033081764     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00872-8     Document Type: Article

References (29)

1. Mann D.L., Young J.B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest. 105:1994;897-904.
2. Kelly R.A., Smith T.W. Cytokines and cardiac contractile function. Circulation. 95:1997;778-781.
3. Pennica D., Shaw K.J., Swanson T.A., Moore M.W., Shelton D.L., Zioncheck K.A., Rosenthal A., Taga T., Paoni N.F., Wood W.I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 275:1995;10915-10922.
4. Kunisada K., Hirota H., Fujio Y., Matsui H., Tani Y., Yamauchi-Takihara K., Kishimoto T. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation. 94:1996;2626-2632.
5. Klappacher G., Mundigler G., Papousek A., Pacher R., Woloszczuk W., Ulrich R., Buxbaum P., Glogar D. Elevated circulating levels of β 2-microglobulin in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 71:1993;119-122.
6. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
7. Testa M., Teh M., Lee P., Fanelli R., Loperfido F., Berman J.W., LeJemtel T.H. Circulating levels of cytokines and their endogenous mediators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 28:1996;964-971.
8. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction a report from the studies of left ventricular dysfunction (SOLVD) . J Am Coll Cardiol. 27:1996;1201-1206.
9. Bendtzen K. Cytokines and natural regulators of cytokines. Immunol Lett. 43:1994;111-123.
10. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 86:1995;1243-1254.
11. Ferrari R., Bachetti T., Confortini R., Opasich C., Febo O., Corti A., Cassani G., Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 92:1995;1479-1486.
12. Moore K.W., O′Garra A., de Wall Malefyt R., Vieria P., Mosmann T.R. Interkleukin-10. Annu Rev Immunol. 11:1993;165-171.
13. Wahl S. Transforming growth factor beta (TGF-β) in inflammation a cause and a cure . J Clin Immunol. 12:1992;61-74.
14. Aukrust P., Ueland T., Müller F., Andreassen A.K., Nordøy I., Aas H., Kjekshus J., Simonsen S., Frøland S.S., Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 97:1998;1136-1143.
15. Liabakk N.-B., Sundan A., Lien E., Lægereid A., Bambara M.P., Ranges G., Espevik T. The release of p55 receptor from U937 cells studied by a new p55 immunoassay. J Immunol Methods. 163:1993;145-154.
16. Svenson M., Hansen M.B., Heegaard P., Abell K., Bendtzen K. Specific binding of interleukin 1 (IL-1)β and IL-1 receptor antagonsit (IL-1ra) to human serum, high-affinity binding of IL-1ra to soluble IL-1 receptor type I. Cytokine. 5:1993;427-435.
17. Aukrust P., Lien E., Kristoffersen A.K., Müller F., Haug C.J., Espevik T., Frøland S.S. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency - possible immunological and clinical consequences. Blood. 87:1996;674-681.
18. Aarden L.A., de Groot E.R., Schaap O.L., Lansdorp P.M. Production of hybridoma growth factor by monocytes. Eur J Immunol. 17:1987;1411-1417.
19. van Zee K.J., Kohno T., Fischer F., Rock C.S., Moldawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and protect against excessive tumor necrosis factor α in vivo and in vitro. Proc Natl Acad Sci USA. 89:1992;4845-4849.
20. Narazaki M, Yasukawa K, Saito T, Ohsugi Y, Fukui H, Koishihara Y, Yancopoulos GD, Taga T, Kishimoto. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 1993;82:1120-1126.
21. van der Poll T., Jansen J., Levi M., ten Cate H., ten Cate J.W., van Deventer S.J.H. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med. 180:1994;1985-1988.
22. Aderka D., Engelmann H., Mao Y., Brakebusch C., Wallach D. Stabilization of the bioactivity of tumor necrosis factor by soluble receptors. J Exp Med. 175:1992;323-329.
23. Geisterfer M., Richards C.D., Gauldie J. Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130). Cytokine. 7:1995;503-509.
24. Lefer A.M., Tsao P., Aoki N., Palladino M.A. jr. Mediation of cardioprotection by transforming growth factor-β Science. 249:1990;61-64.
25. Pradier O., Gérard C., Delvaux A., Lybin M., Abramowicz D., Capel T., Velu T., Goldman M. Interleukin-10 inhibits the induction of monocyte coagulant activity by bacterial lipopolysaccharide. Eur J Immunol. 23:1993;2700-2703.
26. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem. 267:1992;23301-23308.
27. Torre-Amione G., Kapadia S., Lee J., Durand J.-B., Bies R.D., Young J.B., Mann D.L. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
28. Shan K., Kurrelmeyer K., Seta Y., Wang F., Dibbs Z., Deswal A., Lee-Jackson D., Mann D.L. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol. 12:1997;218-223.
29. Bozkurt B., Kribbs S.B., Clubb F.J., Michael I.H., Didenko V.V., Hornsby P.J., Seta Y., Oral H., Spinale F.G., Mann D.L. Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodelling in rats. Circulation. 97:1998;1381-1392.